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Inmates of the Mafanta Prison in Magburaka, Sierre Leone. 
In 2016, Sierra Leone’s Human Rights Commission lashed the squalor and lack of rehabilitative or educational 
programmes in the country’s prisons as «inhumane.» © SAIDU BAH/AFP/Getty Images 2018
Prison is the most glaring expression of the failures of prohi-
bition-based drug policies: the failure to reduce drug demand, 
despite 30 years of states punishing consumption; the failure to 
reduce drug supply and the power of transnational organized 
crime, despite an international drug control regime that has 
existed for over a century. Above all, incarceration is the epitome 
of the human cost of these failed policies.
The global prison population has soared in the last three de-
cades, largely because of the repressive system established by 
the international drug control regime and the national laws that 
derive from it. In our view, deprivation of liberty is the wrong 
response to drug use, as well as to non-violent petty crime ge-
nerated by the illegal market. This is why the Global Commis-
sion on Drug Policy has been calling, since its establishment, 
for the decriminalization of illegal drug consumption, as well as 
for alternatives to incarceration for offenders who were forced to 
engage in illegal activities, whether by lack of other options to 
make a living or coercion by criminal organizations. 
Prison is inevitably an ineffective response because it does not 
take into account the social and psychological root causes of 
problematic drug consumption, nor does it consider the eco-
nomic and social marginalization of traditional coca, cannabis 
or poppy cultivators, nor of women who smuggle small quanti-
ties of drugs, street dealers, or spotters. Prison is also the wrong 
response because people who are incarcerated are vulnerable, 
exposed to risks for which they are not well-equipped, and are 
dependent on those who manage their daily lives. Herein lies 
the paradox of incarceration: the deprivation of liberty inherent-
ly means the inability to think for and to support oneself, in an 
environment where the risk of violence is high, living in promis-
cuity and isolation from friends and relatives.
Even though they are banned, the reality is that illegal drugs 
and other psychoactive substances are largely prevalent in pri-
son. Thus, if incarcerated people consuming drugs also lack 
access to the means that would allow them to reduce the harms 
associated with use, they will be exposed to health risks that are 
far greater than they might otherwise be outside of prison. It is 
therefore essential to offer the full range of treatment options 
for dependency, including opioid maintenance therapies, and 
to allow access to harm reduction means. All these measures 
that have proven to be effective in protecting people against the 
transmission of HIV, hepatitis and tuberculosis need to be im-
plemented in detention facilities, facilities that are by themsel-
ves more “pathogenic,” a situation aggravated by overcrowding. 
Special attention also needs to be given to the risks to which 
people who use drugs are exposed when released from prison, 
as the transition towards their previous lives is marked by 
higher overdose rates than in the general population. 
There are a variety of forms of detention: prisons and jails for 
pre-trial detention or the execution of a sentence, detention 
centers for refugees and illegal migrants awaiting decision on 
their asylum status, and compulsory drug treatment centers. 
Human rights must be upheld as much in these facilities as in 
the community at large: people who are incarcerated need to be 
protected from cruel, inhuman, and degrading treatment, and 
need to have access to care, prevention, and effective treatment, 
based on patient consent and confi dentiality. To guarantee 
these rights for incarcerated people is the shared responsibility 
of health professionals, prison staff, and state authorities – those 
who legislate, judge, or allocate budgets or provide funding – all 
share a responsibility to guarantee these rights to people who 
are incarcerated. No punishment or prison sentence cancels 
these rights.
The Global Commission, while it calls for more sustainable 
and far-reaching reforms in drug policy, can no longer ignore 
the current situation of incarceration and related human rights 
violations. This situation urgently calls for political, correctional, 
and medical authorities to face up to their responsibilities.
Ruth Dreifuss
Former President of Switzerland
forEword
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Since its establishment, the Global Commission on Drug 
Policy has been calling for the decriminalization of illegal 
drug consumption, as well as for alternatives to incarceration 
for low-level non-violent offenders. Today, more than 10 mil-
lion people are incarcerated worldwide. One in five is incar-
cerated for drug-related offenses and of these, 83 per cent 
serve sentences merely for drug possession for personal 
use. The commission views incarceration as an expression 
of the failures of prohibition-based drug policies to achieve 
their goals, and of the failure to implement policies that 
would prioritize the health and rights of individuals and 
communities over criminal justice approaches. 
Prison is the consequence of the failures of drug policy: 
failure to reduce drug demand, drug supply, and the power 
of transnational organized crime. When a state undertakes 
a deprivation of liberty, it has a duty of care and special res-
ponsibility towards those held in detention. Many states, 
however, fail to do so in a number of ways.
Over-incarceration occurs when a state’s criminal justice 
policy provides for incarceration for minor non-violent 
offenses that could otherwise be handled through a 
fine, probation, administrative penalties, or day parole. 
Over-incarceration is also a result of disproportionately 
long sentences for minor non-violent offenses. In fact, most 
people incarcerated for drug-related offenses are either 
people who use drugs or low-level dealers. In addition, 
some states provide for mandatory pre-trial detention for 
all drug-related offenses, whether the offenses are minor 
or high-level in character. Ethnic minorities are far more 
likely to be arrested for drug-related offenses, convicted, 
and sentenced to prison.
This is closely linked to overcrowding, which occurs in more 
than half the countries in the world. It creates a significant 
obstacle to ensuring a minimum standard of treatment 
for people in detention and the protection of their human 
rights. These human rights are mandated by international 
law and treaties, and which states are obliged to apply to 
their citizens whether in the community or in prison, in-
clude the right to health; the right to be treated humanely 
and with respect for one’s dignity; the right to life; the 
right to security of the person; the prohibition of torture 
and other cruel, inhumane, and degrading treatment or 
punishment; the right to privacy and adequate accommo-
dation; and the right to food, water, and sanitation. Prison 
overcrowding contributes to increased rates of violence, 
mental health problems, self-harm, and suicide. It creates 
a high-risk environment for the transmission of HIV, 
hepatitis C and tuberculosis, entailing wider public health 
implications for society once people are released from 
incarceration. 
These practices continue, even though imprisonment has 
been shown to be counterproductive in the rehabilitation 
and reintegration of those charged with minor offenses. 
With regard to drugs, detention is not scientifically recognized 
as an effective way of getting people to discontinue use; 
in fact, drug use in prison is statistically higher than outside: 
approximately 20 per cent of people imprisoned world-
wide use drugs, compared to 5.3 per cent of the general 
population. People can be initiated into drug use while in 
prison, or initiated into the use of different and more harmful 
types of drugs. It has also been estimated that 56-90 per cent 
of people who inject drugs have been incarcerated at some 
point in their lives.
States have the responsibility to protect the right to health 
of those deprived of liberty, and incarcerated people 
should enjoy the same standards of health care as those 
available in the community. This applies to everyone on a 
non-discriminatory basis, including people who use drugs 
and drug-dependent people. States have largely failed to 
meet this standard. For example, in 2016 only 52 countries 
provided opioid maintenance treatment in prisons. The 
situation is worse for needle and syringe programs, provided 
in prisons in only 10 countries, as resistance to their im-
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ExEcutivE Summary
plementation remains high among authorities and prison 
staff. HIV, hepatitis C, and tuberculosis treatment are also 
often less available in prison environments. 
Prisons are high-risk environments for communicable 
diseases such as HIV, hepatitis C, and tuberculosis. Tuber-
culosis is one of the fastest-growing epidemics among 
prison populations and one of the main causes of death, 
particularly in low- and middle-income countries. Incarce-
ration rates and tuberculosis incidence in the general popu-
lation have been found to be directly correlated. Prisons, 
drug use, and HIV are all independent risk factors for the 
development of tuberculosis and amplify each other into 
synergistic comorbid phenomena.
A further problem is the continuity of treatment and care, 
both for people who were receiving treatment when entering 
prison – including for HIV, tuberculosis and other infectious 
diseases, and drug dependence – and for those requiring 
care when they leave. 
These issues are compounded in countries that detain 
people for drug-related offenses without registering or 
charging them, or bringing them promptly before a judge. 
Some even use compulsory drug detention centers, where 
individuals who use (or who may only be suspected of using) 
drugs are confined against their will with the objective of 
constraining them to abandon drug use. Sources estimate 
that over 600,000 people are detained in these centers in at 
least 15 states. Neither detention nor forced labor have been 
recognized by science as treatments for drug use disorders. 
Relapse rates for people released from compulsory drug 
detention centers are very high, and higher than for those 
who undergo voluntary treatment. Drug treatment should 
not involve the criminal justice system. 
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•  States must end all penalties – both criminal and civil 
– for the possession and cultivation of drugs for personal 
consumption. 
•  States must end disproportionate sentencing and punish-
ment for drug-related offenses, and recognize that over-in-
carceration impacts negatively on public health and social 
cohesion. 
•  States must ensure primary health care is available and 
the right to health is applicable to all people on a non-discri-
minatory basis, including people detained against their will. 
•  Practices that violate human rights of people deprived 
of liberty must be forbidden, their perpetrators brought to 
justice, and compensation awarded to victims as provided 
for in human rights law. 
Recommendations 
To address this “perfect storm” of prison overcrowding and inadequate health care for a vulnerable 
group of people who use drugs deprived of their liberty, the Global Commission 
on Drug Policy recommends that:
Since its establishment, the Global Commission on Drug 
Policy has been calling for the decriminalization of illegal 
drug consumption, as well as for alternatives to incarceration 
for low-level non-violent offenders. 
Today, more than 10 million people are incarcerated world-
wide. One in five is incarcerated for drug-related offenses and 
of these, 83 per cent serve sentences merely for drug posses-
sion for personal use. The commission considers incarceration 
as an expression of the failures of prohibition-based drug po-
licies to achieve their goals, and of the failure to implement 
policies that would prioritize the health and rights of indivi-
duals and communities over criminal justice approaches.
When a state undertakes a deprivation of liberty, it has a duty 
of care and special responsibility towards those held in deten-
tion. Failure to fulfil this duty may engage the responsibility of 
the state under national and international law.1, 2
PriSonS worldwidE
As of September 2018, there were an estimated 10.74 million 
people incarcerated worldwide, including those in pre-trial 
detention – prisons representing the facilities where the highest 
numbers of people are deprived of liberty worldwide.3, 4  
Since the year 2000, the world prison population has increased 
by 24 per cent, which is approximately in line with world 
population growth. However, there have been considerable 
variations in the increase in prison populations by regions, with 
increases of 86 per cent in Oceania, 41 per cent in the Americas, 
38 per cent in Asia, and 29 per cent in Africa. In Europe, 
there has been a decrease in prison populations by 
22 per cent, largely as a result of a decrease in prison popula-
tions in the Russian Federation and Eastern and Central Europe, 
attributable in large part to a sharp drop in serious crime rates.5 
The largest increases in prison populations have taken place in 
South America (175 per cent) and Southeast Asia (122 per cent).6 
The 10 countries with the largest number of incarcerated 
people, not counting administrative detention, are the United 
States (2.1 million), China (1.65 million, not including people 
in pre-trial detention), Brazil (690,000), the Russian Federa-
tion (583,000), India (420,000), Thailand (364,000), Indonesia 
(233,000), Iran (230,000), Mexico (204,000), and the Philip-
pines (188,000).7 
over-incarceration
Incarceration should be used only when it is necessary to 
meet the needs of security and safety of people or when other 
non-custodial measures are not adequate, and it should be 
strictly proportionate to the offense committed.8 Over-incarce-
ration occurs when, for example, a state makes excessive use 
of custodial or pre-trial detention and does not respect human 
rights norms in the criminal justice process.9 It can also occur 
when a state’s criminal justice policy provides for incarceration 
for minor non-violent offenses that could be handled through 
a fine, probation, administrative penalties, or day parole. 
Diverting minor non-violent cases out of the system altogether 
may be appropriate in many instances, particularly for cases 
involving drug use or possession of drugs for personal use, or 
other minor drug-related offenses and in cases of people with 
mental health issues, children, and mothers with dependent 
children. The UN Office on Drugs and Crime (UNODC) has 
noted that imprisonment has been shown to be counter-
productive in the rehabilitation and reintegration of those 
charged with minor offenses, as well as for certain vulnerable 
populations.10 Better access to legal representation and legal 
aid may also help reduce over-incarceration.11  
Prison overcrowding 
Prison overcrowding, defined as countries having a prison 
population of more than 100 per cent of official capacity, is a 
reality in more than half the countries in the world. Moreover, 
in more than 20 per cent of countries there is severe prison 
overcrowding, with prison populations at more than 150 per 
cent of official capacity.12 Prison overcrowding is a key factor 
leading to inadequate prison conditions, and creates a signi-
a briEf ovErviEw of incarcEration and drugS  
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ficant obstacle for prison authorities to fulfil their obligations 
to ensure access to health services for people in detention and 
the protection of their human rights. The rights of incarcerated 
people that may be undermined by prison overcrowding in-
clude the right to health; the right to be treated humanely and 
the right to respect for one’s dignity; the right to life; the right 
to security of the person; the prohibition of torture and other 
cruel, inhumane and degrading treatment or punishment; 
the right to privacy and adequate accommodation; and the 
right to food, water and sanitation.13 
Prison overcrowding overstretches prison resources and may 
result in inadequate staffing levels that can lead to an inability 
to ensure the right to security of incarcerated people and to 
protect people from inter-prisoner violence. It may further re-
sult in serious tensions between staff and incarcerated people, 
which can infringe on respect for disciplinary rules and lead to 
disturbances, hunger strikes, and riots to protest conditions of 
imprisonment.14 
Overcrowding can result in situations where detained people 
sleep in shifts or on top of each other, share beds, or tie them-
selves to window bars so that they can sleep while standing. 
Prison overcrowding can also contribute to increased 
rates of violence, mental health problems, self-
harm, and suicide. It can compromise educatio-
nal and vocational programs, recreational 
activities, and the goal of rehabilitation 
of prisoners and preparing them to 
reintegrate successfully into society 
on release.15 Prison overcrowding can 
create a high-risk environment for the 
transmission of HIV, hepatitis C, and 
tuberculosis, entailing wider public 
health implications for society once 
people are released from incarceration.16 
cuStodial and PrE-trial dEtEntion
Custodial and pre-trial detention refer to two slightly different 
situations. Custodial detention refers to a situation where 
people are arrested and subsequently released without being 
charged. The duration of this type of confinement in most 
countries is between 24 and 72 hours, a period of time that 
conforms to international human rights law. In a significant 
number of states, large numbers of people are arrested, de-
tained, and subsequently released relatively quickly without 
being charged.17 
Pre-trial detention is a situation where a person has been ar-
rested and charged with a crime, and a judge has determined 
that the charged individual should be held in pre-trial de-
tention while awaiting trial, rather than being released pen-
ding trial. It is not the general rule that a person arrested and 
charged shall remain in pre-trial detention, and the UN has 
said that, “under international law, detention prior to convic-
tion must be the exception, not the rule.”18 
custodial detention: 
a period of vulnerability
If people are arrested and not released promptly without 
being charged, human rights law obliges states to charge 
the arrested person with a criminal offense and to bring 
them within a short time before a judge to determine 
whether the arrest was arbitrary. For an arrest 
to be lawful, there must be a basis in cri-
minal law for the arrest, and applicable 
legal procedures for the arrest must be 
observed.19 The UN High Commissio-
ner for Human Rights has expressed 
concern that in some countries, 
people were arrested for drug-re-
lated offenses and were neither re-
gistered, nor charged, nor brought 
promptly before a judge.20, 21
In custodial detention, a serious concern 
for people arrested for drug-related of-
fenses who have not yet been charged with 
any crime is that they may be subjected to torture 
and/or cruel, inhumane, or degrading treatment or punish-
ment. In many countries, law enforcement relies heavily on 
confessions as evidence that an individual has committed 
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“Studies show that the 
US has among the highest 
rates of drug use in the world. 
But even as restricting supply has 
failed to curb abuse, aggressive 
policing has led to thousands of young 
drug users filling American prisons, 
where they learn how to become
 real criminals.”
George P. Shultz, Honorary Chair 
of the Global Commission on Drug 
Policy.[1]
[1] NYT, 31 Dec 2017
an offense. Therefore, law enforcement may arrest someone 
on only a suspicion that a person has committed a drug-re-
lated offense, and may use brutal withdrawal symptoms and 
other forms of punishment until the person confesses to a 
crime. Torture and other forms of ill treatment are also used 
to obtain information about other people who use drugs and 
about traffickers involved in the drug trade.22 
Pre-trial detention: the source 
of overcrowding
Excessive use of pre-trial detention for drug-related offenses 
has made a significant contribution to prison overcrowding. 
It has been reported that law enforcement authorities in 
some countries have targeted areas at or near drug treatment 
centers in order to make arrests. People who use drugs may 
constitute an easy target for arrest for law enforcement offi-
cials who feel pressured to meet certain arrest goals or quo-
tas. It has also been reported that people who use drugs may 
be harassed by law enforcement officials for money or sex to 
avoid arrest. 
Factors considered in determining whether a person is re-
leased or held in pre-trial detention include whether 
the individual is potentially a flight risk, whether 
there is a danger of destruction of evidence, 
and whether there is a reasonable likeliho-
od that the person may commit another 
crime. If the person is released pending 
trial, guarantees may be required so 
that the person appears at all stages of 
judicial proceedings. The Human Rights 
Committee has determined that pre-trial 
detention should not be mandatory for 
any particular criminal offense and that it 
should not be ordered for a period based on 
the potential sentence for the alleged crime.23 
The Inter-American Commission on Human Rights 
has also declared the practice of automatic pre-trial deten-
tion for a specific crime to be a human rights violation.24 All 
of these practices should be considered as arbitrary arrest 
and detention, and as causing an increase in the number 
of people deprived of liberty. It has also been reported that 
people in poor or marginalized areas where there is often 
more street activity may also be targeted or “over-policed.” Re-
ports indicate that law enforcement action against people who 
use drugs and micro-traffickers disproportionately targets mi-
norities, women, and the poor.25 The Committee on the Elimi-
nation of Discrimination against Women expressed concern at 
the number of women imprisoned for drug-related offenses 
in the United Kingdom, and observed that this may be a re-
flection of women’s poverty.26 In some states, pre-trial deten-
tion for drug-related offenses can be for a period of months or 
even years. Some countries, such as Bolivia, Brazil, Ecuador, 
and Mexico, provide for mandatory pre-trial detention for 
all drug-related offenses, whether the offenses are minor or 
high-level in character.27 
PEoPlE who uSE drugS and PriSonS
It has been estimated that approximately one in five people 
in prison worldwide, or over 2 million people, are incarce-
rated for drug-related offenses.28 Of the latter, approximately 
83 per cent are serving sentences for drug possession for 
personal use.29 
Most other people incarcerated for drug-re-
lated offenses are low-level dealers or mi-
cro-traffickers. In the United States, the 
majority of small-scale drug offenders 
have no history of violence.30 In Colom-
bia, it was estimated that only 2 per cent 
of people convicted for drug-related 
offenses were medium to high-ranking 
figures in the drug trade.31 Over-incarce-
ration for drug-related offenses is a result 
of disproportionately long sentences for 
minor non-violent offenses. In many countries, 
mandatory minimum sentences and dispropor-
tionately long sentences have resulted in sentences for 
drug-related offenses that are longer than for murder, rape, 
kidnapping, or bank robbery.32 
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“The widespread 
criminalization and 
punishment of people who 
use drugs, 
the over-crowded prisons, mean 
that the war on drugs is, to a 
significant degree, a war on drug 
users – a war on people.”
Kofi Annan, member of the Global 
Commission on Drug Policy, 
2016.[2]
[2] Der Spiegel, 22 Feb 2016
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Testimony
 nayeli- Bolivia
I was five years old when I moved into a prison for the first time. They caught my father transporting two and a half tons of cocaine base 
paste. My whole family, all seven children, moved in with my dad. We would go to a daycare center outside from 7am until 5pm. We 
lived there for seven years, the full length of his sentence. 
When he got out, he couldn’t feed all of us. In 8th grade, I decided to get a part-time job in a cumbia music band. Later, I quit school 
to work full-time in music to help provide for my family. Unfortunately, a band member raped me; it was the first time I had had sex, 
but I got pregnant. The baby’s father rejected him, moved to Spain, got married and started a family. When he returned several years 
later,  he took my son away from me.
My next partner beat and cheated on me, but I thought it might be different if we moved to Argentina.  I was wrong. I had another son 
there, so I took him back to Bolivia and began working as a secretary for a taxi company. It didn’t pay much. After a while, someone 
offered me 1,500 USD to swallow  “small capsules” and take them to Chile in my stomach. I took 900 grams of cocaine my first time. 
I did it twice.
In 2014, they arrested me at my house while I was getting ready for a third trip. I qualified for a government pardon, intended to ease 
prison overcrowding, so I only spent four months in prison. 
After my release, I got a loan to start a small business, but it didn’t go well. I couldn’t pay it back, so I agreed to go back to Chile with 
three large packages of cocaine base paste taped to my legs for 2,000 USD.  I never made it out of Cochabamba, my friend’s boyfriend 
told the police what we were doing. I went back to prison in 2015 and got an eight-year sentence.  As a repeat offender, I no longer 
qualify for pardons. I live there now with my second son.
Life in prison is really sad, and those of us that have no one feel lonely all the time. My mother used to visit, but she passed away, and 
I couldn’t go to her funeral. I ask myself, what have I done to deserve this? I know that a lot of people suffer because of drugs, but I am 
not a murderer. 
Life in prison is hard. Sometimes there’s no water to shower or wash your hands or clothes.  I don’t always have enough money to 
buy food for my son and me. People occasionally donate fruit and vegetables, but inmates fight to get them. If you need to go to the 
hospital, you have to work through the system to get a special permit. You can’t go without it, you have to prove that you’re sick.
When I get out, I want to move far, far away from here. I don’t want to stay in Cochabamba. I want to move somewhere else with my 
younger son and start a new life. I haven’t seen my oldest son since 2015. He doesn’t know I’m in prison, and I don’t want him to find 
out. I’m ashamed. I want to get custody of him after my release. There are so many things I want to tell him. I hope he can forgive me.
the “war on drugs” and international conventions
In the United States, the high rate of incarceration for drug-re-
lated offenses dates back to the “war on drugs” that began 
in 1971. In 1980, there were 40,900 people incarcerated for 
drug-related offenses in federal and state prisons; by 2015, the 
number had grown dramatically to 469,545.33 This substantial 
increase in incarceration for drug-related offenses was further 
encouraged by the adoption of the UN Convention against 
Illicit Traffic in Narcotic Drugs and Psychotropic Substances 
of 1988. This convention required criminalization of the per-
sonal use of drugs, as well as the possession or acquisition of 
drugs, unless it was incompatible with a state’s constitutional 
principles and the basic concepts of its legal system (Article 
3 (c)(1)). It also required the criminalization (but without pro-
viding for non-application in cases of non-conformity with a 
state’s constitutional principles and the basic concepts of its 
legal system of production) of any “manufacture, extraction, 
preparation, offering, offering for sale, distribution, sale, or 
delivery of illicit drugs” (Article 3(a)(1)).
Although drug use rates are similar between ethnic minori-
ties and the majority populations in Australia, Canada, the 
United States, and the United Kingdom, ethnic minorities are 
far more likely to be arrested for drug-related offenses, convic-
ted, and sentenced to prison, according to studies conducted 
on the subject.34 It has been posited that, in addition to ra-
cial discrimination, this is also due to heavy policing of poor 
neighborhoods and those areas where ethnic minorities are 
concentrated.35
The international drug conventions provide for diversion for 
drug-related offenses of a minor nature, if compatible with a 
state’s constitutional principles and the basic concepts of its 
legal system.36 Nevertheless, and despite the fact that both 
UNODC and the World Health Organization (WHO) have 
called for diversion of people with problematic drug use from 
the criminal justice system,37 many countries continue to punish 
minor drug-related offenses severely, including drug use and 
possession for personal use. Many also set low thresholds 
for qualifying drug possession as a trafficking offense, which 
inevitably carries much stiffer criminal sanctions.38
drug use among incarcerated people 
Drug use is widespread in places of incarceration. It has been 
estimated that approximately 20 per cent of people imprisoned 
worldwide use drugs, much higher than the 5.3 per cent of the 
general population.39 Drug use among those incarcerated is 
not limited to those who have been convicted for a drug-re-
lated offense, but can also be prevalent among those who 
were imprisoned for offenses unrelated to drugs.40  
Prisons may be a setting where a person is initiated into drug 
use, or into the use of different and more harmful types of 
drugs. The type of drugs used may be influenced by the lack 
of preferred substances within prison or because a particular 
substance can be concealed more easily to avoid detection. In 
one study, it was found that one-third of incarcerated people 
started to use a drug while incarcerated which they had not 
used before, with the most common substance being heroin.41
It has also been estimated that 56-90 per cent of people who 
inject drugs have been incarcerated at some point in their lives.42 
In Eastern Europe and Central Asia, for example, people who 
inject drugs represent 30-80 per cent of prison populations.43 
It is estimated that drug injection among people in prison 
ranges from 2 to 38 per cent in Europe, 34 per cent in Canada, 
and 55 per cent in Australia.44 
As noted before, the majority of incarcerated people tend to 
come from poor communities or marginalized ethnic groups. 
In addition, people experiencing incarceration tend to suffer 
from high levels of physical and psychiatric disorders, the 
latter including antisocial and personality disorders, depres-
sion, or post-traumatic stress disorder. Given that some or 
all of these factors weigh on people who have been incarce-
rated, drug use and drug dependence are disproportionately 
higher in prisons than in the general population.45 
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Testimony 
yatie Jonet – Malaysia
I dropped out of school when I was just 15, presumably because my parents did not know enough about the issues affecting teens and 
how to deal with them. As a high school dropout, I took my own path and, unaware of the consequences, I started consuming drugs 
everyday, with different forms and methods of consumption, most of them harmful. I had no idea, there was no information available. 
I injected drugs for two years and ended up contracting hepatitis C in 2013, four years after I was last released from detention centers.
I would resort to petty crime to support my daily intake and started selling drugs after my partner was detained and jailed for a drug 
offense. I often had no choice but to bribe local law enforcement officers with money and sex so I wouldn’t end up in jail. I have said 
nothing until today about this out of fear of being killed or forcefully disappeared.
But of course, I was often arrested. I would be detained in a lockup for a month, a month and a half, without any access to treatment, 
before being sent to prison. I have been in and out of prison, carrying a lifetime criminal record because of my drugs offenses, the 
same as with other users. We’re an easy target to catch again and again. As a person using drugs, you are seen as the public enemy 
number one in Malaysia.
In addition to not having access to proper health care, I was unable to be a mother to my son. I lost the essence of motherhood, unable 
to feel and nurture motherly instincts because I was consistently separated from him, either because I was afraid of losing my supply 
of drugs by staying with my family rather than my boyfriend/dealer, or when I was in prison.
Finally, I managed to stop injecting drugs, working as an outreach worker passionately sharing essential information about harm 
reduction programs and emphasizing treatment and health care, as well as sharing my personal experiences. After years of serving my 
community with a civil society organization, I became who I am today despite being neglected, rejected for being myself. I am now 
pursuing my goals advocating for an urgent need to reform global drug polic and protect fundamental human rights by shaping a 
nation with that offers an enabling and safe environment for our future generations.
In general, almost everyone was against my openness about my active drug use and I was constantly labelled a “liberal”, even amongst 
those in my community so close to my heart, who came from various backgrounds and consisting of people who formerly used drugs 
and live with lifetime criminal records and with infectious diseases . And even though they have completely stopped using drugs, 
they still are unaware of the negative consequences of the punitive drugs policy that enforces zero tolerance and abstinence-only 
approaches.
I continue to dream about getting a certificate or something that would allow me to live in dignity. For a person who uses drugs, being 
acknowledged as a human being and not just an object of study in drugs and drug use would already be a victory.
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infEctiouS diSEaSES ProlifEratE in PriSonS
hiv and hepatitis c fueled by incarceration 
Injecting drug use is known to be an independent risk factor 
for acquiring blood-borne infections such as HIV and hepa-
titis C. For instance, injecting drug use is the driving force 
of the HIV epidemic in Eastern Europe and Central Asia, the 
only regions in the world (with the Middle East and North 
Africa) where the number of new HIV cases continues to in-
crease. Around 60 per cent of these new cases are co-infec-
ted with hepatitis C.46 Prisons are high-risk environments for 
spreading communicable diseases such as HIV, hepatitis C, 
and tuberculosis.
Treatment options such as opioid substitution therapy (OST),47 or 
harm reduction measures such as needle and syringe ex-
changes, are very limited (if available at all) in prison systems 
worldwide. Resistance to their implementation remains high 
among authorities and prison staff.48 Consequently, people 
who have been incarcerated are forced to share needles and 
syringes, thereby creating the conditions for further spread 
of HIV and hepatitis C. In Canada, the prevalence of HIV in 
prisons is estimated to be 10 times higher than in the ge-
neral population, whereas the prevalence of hepatitis C is 
30-39 times higher.49 In Ukraine, it was reported that almost 
57 per cent of incarcerated people were injecting drugs in 
prison, each needle/syringe being shared by a mean 4.4 
people who inject drugs.50 Incarceration is implicated as a 
driver of HIV transmission among people who inject drugs. 
Prevalence among incarcerated people who inject drugs in 
the country exceeds 20 per cent, and at least 28-55 per cent 
of all new HIV infections can be attributed to incarceration.51 
A history of incarceration has been shown to be associated 
with HIV and hepatitis C infections.52 
The availability of effective antiretroviral treatment (ART) 
in the context of HIV infection varies in settings where re-
sources and reach are limited. However, in prisons it is avai-
lable to a much lesser extent, as is access to health care in 
general.53 Without ART, in the presence of drug use under 
poor living conditions combined with overcrowding and pro-
miscuity, HIV infection may progress rapidly, putting people 
living with HIV at a high risk of developing tuberculosis, a 
devastating infectious disease that is an integral part of pri-
son environments. 
“THE GLOBAL STATE OF HARM REDUCTION” AND OPIOID SUBSTITUTION TREATMENT IN PRISONS: 
In spite of the international human rights frameworks calling for the right to health to be provided for people who use 
drugs, and for the same level of health care to be provided for people who use drugs who are incarcerated, states have 
largely failed to meet these standards. For example, in 2016 only 52 countries provided opioid maintenance treatment 
or substitution therapy in prisons. In a significant number of countries, OST is available only in a limited number of 
prisons and is frequently lacking in prisons for women. As for harm reduction, the situation of needle and syringe programs 
is worse, with only 10 countries providing such programs. Concerning overdose prevention training and distribution of 
opioid antagonists such as naloxone to people in detention prior to or at release from confinement, only five countries 
provide such training and distribution; although in the cases of Canada and the United States, this measure is further 
restricted to a limited number of provinces or states respectively.54 
hEalth and dEPrivation of libErty
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tuberculosis 
Tuberculosis is a disease caused by the mycobacterium tu-
berculosis bacillus. The disease is spread when people who 
are sick with pulmonary tuberculosis expel bacteria into the 
air that is then breathed in by other people. The risk of deve-
loping active tuberculosis increases dramatically when the 
immune system is compromised by HIV, drug use, alcohol, 
malnutrition, or poor living conditions. The risk of develo-
ping active tuberculosis can reach 30 per cent or more under 
these conditions. 
The optimal way to prevent the development of active tuber-
culosis, and thus the spread of the infection, is to identify 
and treat those with so-called latent tuberculous infections, 
who are at risk of developing active forms of the disease. 
Unfortunately, this is rarely done in prison settings and data 
on prevalence of latent tuberculous infection in prisons is 
scarce. In Spain, a prevalence of latent tuberculous infection 
of approximately 55 per cent has been documented among 
those imprisoned in Madrid, compared to 15 per cent in the 
general population nationwide.55 A similar pattern of latent 
tuberculous infection prevalence was also reported in Brazil.56
Prisons create particularly high-risk environments for the 
transmission of tuberculosis due to close contact between 
large numbers of high-risk individuals over extended time 
periods, overcrowding, and poor ventilation and hygiene. 
Furthermore, prison-associated risk factors, such as malnu-
trition, stress, HIV, hepatitis C and other comorbidities, and 
problematic drug and alcohol use promote transmission of 
mycobacterium tuberculosis between incarcerated people. 
Prison environments serve as a reservoir of tuberculosis 
and facilitate new infections where infection with myco-
bacterium tuberculosis progresses rapidly to become active 
tuberculosis or causes re-activations of latent tuberculous 
infections. Prisons, drug use, and HIV are all independent 
risk factors for the development of tuberculosis, yet when 
combined create a “perfect storm” by amplifying each other 
into a synergistic comorbid phenomenon.57 
drug use and poor detention conditions: 
the “perfect storm”
Despite the existence of well-known preventable mea-
sures that are easy to implement, tuberculosis is one of the 
fastest-growing epidemics among prison populations and 
one of the main causes of death, particularly in low- and 
middle-income countries, where the prevalence of tubercu-
losis in the general population is also high. Indeed, prisons 
are recognized as critical social vectors for the transmission 
of tuberculosis into society, and a direct correlation between 
incarceration rates and tuberculosis incidence in the general 
population has been found.58 
Data suggests that prisons contribute substantially to tuber-
culosis epidemics among the general population, but espe-
cially for people who inject drugs and especially in countries 
where tuberculosis is endemic. For example, in Ukraine, 
although only 0.5 per cent of the adult population was in-
carcerated, it has been estimated that 6 per cent of all new tu-
berculosis cases result from incarceration. Among people who 
inject drugs, this increases to 75 per cent for those living with 
HIV and to 86 per cent among those free from HIV.59 
With treatment, tuberculosis is a curable disease. However, 
tuberculosis control in prisons is complicated by low cure 
rates due to delayed diagnosis; poor isolation facilities; 
treatment interruptions due to lack of drug supply or poor 
There is a negative 
and mutually reinforcing 
impact of incarceration, drug use, 
tuberculosis, HIV and hepatitis. 
Overincarceration of people who use 
drugs creates a high-risk environment 
for diseases and their onwards 
transmission to the community 
after release.
Michel Kazatchkine,  
member of the Global Commission 
on Drug Policy   
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adherence; and, in consequence, development of mul-
ti-drug resistant tuberculosis. People are often released into 
the community before treatment completion and without ef-
fective transitional care.60 Transmission of tuberculosis to the 
community occurs not only after release, but also through 
visitors and prison staff. Findings from a modelling study in 
Brazil suggest that the prison environment, more so than the 
prison population itself, drives tuberculosis incidence, and 
targeted interventions within prisons could have a substan-
tial effect on the broader tuberculosis epidemic.61 Tubercu-
losis and HIV in prisons remain neglected public health and 
human rights issues in many countries worldwide, where 
the rights of incarcerated people to adequate health care are 
being violated and treatments are not available. Even where 
treatments are available, incarcerated people often tend to 
take medication irregularly, in order to become sicker and 
get an opportunity for transfer into a facility with better 
conditions.62 Irregular treatment creates conditions for the 
development of multi-drug resistant tuberculosis (MDR-TB), 
which requires a longer treatment duration (up to two years, 
compared to six months for drug-sensitive tuberculosis), 
more toxic drugs, higher costs, and results in significantly 
lower cure rates. 
The tuberculosis epidemic in prisons is a particular challenge 
for public health, and is an economic and social problem in 
sub-Saharan Africa, Eastern Europe and Central Asia.63 Eas-
tern Europe and Central Asia have the world’s highest pro-
portions of multi-drug resistant tuberculosis (MDR-TB) at 9 to 
35 per cent of new tuberculosis cases and 49 to 77 per cent 
of re-treatment cases in Belarus, Russia, and Ukraine, com-
pared with 1 to 3 per cent of new cases and 4 to 14 per cent 
of re-treatment cases in Italy, Switzerland, and the United 
Kingdom.64 
Considering the prison environment and risk groups des-
cribed above, there is a potential threat that the spread of 
MDR-TB between people detained, prison staff, and into the 
community will further increase unless urgent measures are 
taken. Strategies to reduce the incarceration of people who in-
ject and/or use drugs would have the greatest impact. Opioid 
maintenance therapy, of which the positive effect on the health 
and behavior of people who inject drugs is well documented,65 
along with harm reduction services, should be widely imple-
mented in prisons and be available to all in need. Expansion 
of prison-based OST with effective community transition after 
release could be an effective strategy to reduce transmission 
of tuberculosis, HIV, and hepatitis C. Prison workers need to 
be educated and trained in harm reduction and to view these 
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GHAVTADzE V. GEORGIA 
(NO. 23204/07), OR
 THE OBLIGATION FOR STATES TO 
PROTECT THE PHYSICAL
 INTEGRITY OF 
PEOPLE INCARCERATED
In June 2009, the European Court of Human Rights 
(ECHR) found Georgia in breach of Article 3 of the Eu-
ropean Convention on Human Rights (the prohibition 
of inhuman or degrading treatment). The case was put 
forward by Irakli Ghavtadze, a person who injects drugs, 
and who was arrested and sentenced to 11 years in pri-
son on gun charges. A few weeks into his incarceration, 
the plaintiff started showing symptoms of viral hepatitis. 
He was taken out of hospital twice by penitentiary ser-
vices, and was also infected with scabies and tuberculo-
sis. While the ECHR could not establish whether the 
hepatitis infection occurred in prison, the court stated 
unanimously that the Georgian authorities violated the 
prohibition of inhuman treatment against Mr. Ghav-
tadze, confirmed his right to health, and mandated the 
authorities to place him immediately in treatment faci-
lities able to address his infections with hepatitis B and 
C, as well as tuberculosis. Moreover, the judgment also 
required authorities to take appropriate individual and 
general measures to prevent the spread of contagious 
diseases in Georgian prisons, introduce a tuberculosis 
screening system for incarcerated people upon admis-
sion, and guarantee the prompt and effective treatment 
of these diseases.
 Testimony  
anonymous– Russia
I was placed in a pre-trial detention facility while I was suffering from withdrawal, as a consequence of being held in a department where 
a criminal case was initiated against me under Article 228 point 2. Withdrawal was so severe and painful that an ambulance was called, 
but, apart from giving me an injection of a mild anti-spasmolytic “No-Spa”, the doctors didn’t help much. I was taken into detention in the 
evening and, because I was constantly nauseous, I asked to call an ambulance. I received the following answer: “Are you fucking out of your 
mind, you junkie? Look how many of you are here – do you seriously expect us to call an ambulance for every single one of you?” 
Later, I overheard their exchanges: “Maybe we should take him to Semyon?” I found out later that Semyon was the chief officer of the facility. 
I was then taken into quarantine for the recently arrested. The quarantine cell, initially intended for 21, held almost 70 inmates. We took 
turns sleeping on bunk beds three at a time. Cigarette smoke hung in the air. I introduced myself and explained that soon I will go into wit-
hdrawals. My fellow inmates were understanding: as it turned out, three quarters of the people there went through the same experience. 
People shared advice: they told me the best things to do and gave me a place to sleep. They really understood what I was going through. 
On the first day, everything was more or less fine – I think that the overall stressful state I was in, the adrenaline, helped me to cope with the 
symptoms on the first day. On the second day, I was in hell. People in the cell around me helped as they could. On the third day, I asked for 
a doctor who only showed up two hours later! I complained about my health and he declared: “Are you fucking insane, you junky? If you 
dare call me again, I will send you to isolation.” He gave me two Ketorolac (Toradol)* pills. Then I was very ill – I vomited all the time and I 
thought that was going to die. The inmates called the doctor again who came, looked at me, and did nothing.
Around the fifth or the sixth day, it got a little better, but I couldn’t sleep. Sleep was basially just fainting for thirty minutes to an hour at a 
time. This lasted for about a month, a time during which I had called the doctor twice, both times to ask for medication to help me sleep. He 
refused, threatening to throw me in isolation or into a “looney-cell” (a cell for inmates with mental disorders). 
About ten days later, they started taking me to the so-called “investigation-related activities” (interrogations, cross-examinations, etc.). 
Once, I was brought in for a talk with the chief officer who offered: “I have a deal for you. If you admit to breaking into the apartment (I was 
expected to plead guilty for breaking into an apartment and for a theft that I did not commit), I will give you 5 grams.” I replied that I had 
to think about it. Obviously, I didn’t want to do time for a crime I didn’t commit, but my craving for drugs was bad. I was asked the question 
again a second time, and I categorically refused.
Overall, what I can tell you from this experience is that to find oneself in a Russian detention facility – without a single trace of humane 
conditions –constitutes a severe punishment in itself. To be held there while in withdrawals is torture, pure and simple! The medical staff – if 
there’s any at all – gives you no assistance. The only thing that does help is the mutual support of the fellow inmates who understand the 
situation.
* A nonsteroidal anti-inflammatory drug used to treat pain.
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measures as a high priority.66 There is also a 
need to develop cost-effective interventions 
to diagnose, treat, and prevent tuberculosis 
transmission among the incarcerated 
population.
thE right to hEalth in 
PriSonS: obligationS undEr 
intErnational law
The right to health is applicable to all people 
on a non-discriminatory basis, which means 
that people who use drugs and drug-dependent 
people cannot be subjected to discrimination in the pro-
vision of health care. Indeed, the right to health extends to 
assessment and treatment for drug dependency, and harm 
reduction services have been recognized as part of the right to 
health for people who use drugs. 
According to the Mandela Rules (the UN Standard Rules for 
the Treatment of Prisoners), the provision of health care for 
those incarcerated is a state responsibility, and incarcerated 
people  should enjoy the same standard of health care as that 
available in the community, free of charge 
and without discrimination on the grounds 
of their legal status (Rule 24, para. 1). The 
provision of health care in prisons to the 
same standard as that available in the 
community has also been advocated by 
WHO. Health care should be organized in 
close relationship with the general public 
health administration, and in a way that 
ensures continuity of treatment and care, 
including for HIV, tuberculosis and other in-
fectious diseases, as well as for drug dependence 
(Rule 24, para. 2). The Mandela Rules also have a 
provision that the physician or other qualified health care pro-
fessional who examines each incarcerated individual as soon 
as possible following his or her admission, and thereafter 
as necessary, shall focus particular attention on symptoms 
of withdrawal from the use of drugs and undertake all appro-
priate individualized measures and treatment (Rule 30). 
The Bangkok Rules (the UN Rules for the Treatment of Women 
Prisoners and Non-custodial Measures for Women Offenders), 
which are designed to complement the Mandela Rules, state 
“A  prohibitionist 
approach [to drug policy] 
is mandated by the UN 
conventions, which refer to 
drug addiction as an ‘evil’. 
It is a short step from that to 
seeing those who use drugs as 
evil and deserving of 
punishment.” 
Helen Clark, member of the Global 
Commission on Drug Policy, 
Auckland, March 
2019   
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With the adoption of the Sustainable Development Goals (SDGs) in 2015, the international community pledged to “end 
the epidemic of tuberculosis (TB) by 2030” by reducing its incidence among all populations.67 With 1.3 million deaths an-
nually, tuberculosis is currently the leading cause of death from infectious disease in the world. Its incidence has declined 
at an annual rate of 2 per cent over the last 15 years, whereas its elimination by 2030 requires a decline of 4 to 5 per cent 
per year.68 In prison, the levels of tuberculosis are reported to be 100 times higher than in the general population, and up 
to 24 per cent of all tuberculosis cases in prison could be MDR-TB.69 Moreover, it is estimated that less than 5 per cent of all 
countries will be able to eliminate tuberculosis by 2030.70 
Due to the lack of effective measures to control TB, the concentration of almost half of TB cases in BRICS countries, and with 
a third of antimicrobial resistance (AMR) deaths related to TB, tuberculosis has been on the political agenda of the G20 
since 2017, and the international community approved the first political declaration on TB in September 2018.71 
  
TUBERCULOSIS ELIMINATION AND THE SUSTAINABLE DEVELOPMENT AGENDA :
AN AIM IN SEARCH OF POLITICAL WILL
that the state should provide for gender-sensitive, trauma-in-
formed, women-only treatment programs in the community 
(Rule 62). 
With respect to children who use drugs, the Committee on the 
Rights to the Child (in its general comment No. 15, 2013) 
endorsed harm reduction as an important approach to minimi-
zing the negative health effects of substance use. It has recom-
mended that children receive accurate and objective informa-
tion on drugs and that they should not be subject to criminal 
proceedings. The committee has called for the possession of 
drugs by children to be decriminalized.72 
Poorly PrEParEd PriSon-rElEaSES and 
hEalth riSKS
A major challenge for countries is not only to improve health 
care and harm reduction services dramatically for drug-de-
pendent people in prisons and other detention centers, but 
also to coordinate health care management for incarcerated 
people who are drug-dependent on release with health care 
providers in the community. The individual leaving prison 
with a continuity of health care in the community has a greater 
chance of positive health outcomes, especially when the risks 
of overdose deaths are very high after release. 
In Ontario, one in 10 overdose deaths happens to former in-
mates within a year of release. The risk of overdose death is 
extremely high in the fi rst two weeks of release, and has been 
estimated at 56 times the risk in the general population. In-
deed, it has been posited that the forced break from drug use 
while in prison lowers the tolerance of incarcerated people, 
and that even if they were able to procure and use drugs while 
in prison, the drugs they can procure and use after release 
are stronger.73 Other studies have made similar fi ndings. For 
example, a study in North Carolina in the United States found 
that people formerly incarcerated were 40 times more likely 
to die of an opioid-related overdose than someone in the ge-
neral population. Moreover, when restricted to heroin-related 
overdose deaths only, the likelihood of death increased to 
74 times higher compared to the general population in the 
fi rst two weeks after release.74
More than 80% of all detainees in Haiti are being held in prolonged pretrial 
detention during which detainees can wait between four and six years for their 
court cases to be heard. © UN Photo/Victoria Hazou 2012
Inmate of a compulsory drug detention center in the northern city of Hai Phong, Vietnam 
© HOANG DINH NAM/AFP/Getty Images 2017
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StatE-run comPulSory drug 
dEtEntion cEntErS
Compulsory drug detention centers have been variously called 
compulsory treatment centers, drug rehabilitation centers, com-
pulsory detoxification centers, or centers for social education 
and labor.75 Such facilities are settings where individuals who 
use drugs, or who may only be suspected of using drugs, are 
confined against their will with the objective of constraining 
them to abandon the use of drugs. In most cases, there is no 
clinical evaluation of whether they encounter problematic drug 
use or not. There is usually no or little legal process associated 
with the confinement, and no appeal process.
Large-scale compulsory drug detention centers originally 
gained prominence in East and Southeast Asia. One source es-
timated that 450,000 people were confined in seven countries 
(Cambodia, China, Lao People’s Democratic Republic, Malaysia, 
the Philippines, Thailand, and Vietnam) in 2014.76 Another 
source estimated the number of detainees in various centers 
in the region at 600,000.77 These numbers may actually under- 
estimate the number of people in confinement in compulsory 
drug detention centers worldwide, as they have been found in 
at least 15 states (Brunei, Cambodia, China, Egypt, Indonesia, 
the Islamic Republic of Iran, Lao People’s Democratic Republic, 
Malaysia, Myanmar, the Russian Federation, Saudi Arabia, Sin-
gapore, Sri Lanka, Thailand, and Vietnam).78 
Procedures for committing people who use drugs, or allegedly 
use drugs, vary from country to country. Detention is based on 
administrative law in some countries and criminal law in others. 
Individual arrests by law enforcement, mass arrests in major 
drug crackdowns, testing positive for drugs in a urine test, or 
being turned over by family or community members, can all 
lead to detention. 
In the case of states where administrative law is the basis for 
confinement, detainees may be designated as victims, patients 
(e.g. Cambodia, Laos, Thailand),79 or people engaged in beha-
vior considered as a social evil (e.g. Vietnam). In countries such 
as Cambodia and Laos, it has been reported that those detained 
for drug use have been kept in facilities with other people 
deemed “undesirable” by society, such as people with proble-
matic alcohol use, homeless people, sex workers, and people 
with mental disabilities.80 
Human rights abuses that have been reported in compulsory 
drug detention centers include arbitrary detention, beatings, 
whipping, other physical and verbal abuse, torture and other 
forms of ill treatment, sexual violence, forced labor, solitary 
confinement, denial of adequate health care, deplorable living 
conditions characterized by poor ventilation and sanitation, 
overcrowding, and poor nutrition. Beatings in response to 
minor infractions of the rules can be severe, and reports have 
indicated that they can result in broken limbs or rendering the 
person unconscious. There have also been reports of detainees 
being tied up for hours in the sun without food or water.81
Thousands of children are also detained in such facilities. Family 
members may request local authorities to detain children sus-
pected of using drugs, because they believe detention centers 
to be therapeutic (against scientific evidence), or they may be 
picked up in operations by law enforcement in an attempt to 
“clean the streets.” In some cases, they may be detained because 
they are the children of homeless people or beggars found du-
ring drug enforcement operations. The detention of children 
violates human rights in a number of ways: it is considered ar-
bitrary, since detention of children should only be a measure of 
last resort, and they should not be housed with adults; and any 
deprivation of liberty shall only take place after “the juvenile is 
adjudicated of a serious act involving violence against another 
person or of persistence in committing other serious offenses, 
and unless there is no other appropriate response, according 
to the UN Standard Minimum Rules on the Administration of 
Juvenile Justice.”82 
In China, repeat offenders who have first been in community 
treatment programs can be held in compulsory drug detention 
centers for two years, with flexibility allowing for early release 
or an additional year in detention. In Vietnam, initial detention 
comPulSory drug dEtEntion cEntErS 
and adminiStrativE dEtEntion
may last two years, but can be extended for another two 
years following an evaluation of the detainee. In Malaysia, 
a person with a positive urine test and who is deemed to 
be drug-dependent by a government medical officer can be 
detained for up to two years, although a mean period of de-
tention of 7.5 months was cited in one study.83 
While the approach varies slightly from country to country, 
compulsory drug detention centers generally regard the 
use of drugs as a matter of free will, and therefore 
focus on trying to change the personality of 
the detainee so that he or she will abandon 
drug use. Detainees in compulsory drug 
detention centers are often subjected to 
long hours of physically strenuous and 
exhausting exercise. Other compulsory 
drug detention centers provide spiritual 
counselling to detainees.84, 85 In addition to 
military-style strenuous physical exercise 
programs and harsh discipline, compulso-
ry drug detention centers in some countries 
also require forced labor (e.g. Cambodia, China, and Vietnam),86 
which has sometimes been referred to as labor therapy. De-
tainees are obliged to work long hours, either with no pay or pay 
significantly below market rates.87 In some cases, this work is 
dangerous or physically arduous, such as in construction or agri-
culture, and often no proper protective gear is provided. Forced 
labor for the manufacture of clothing, shoes, and handicrafts 
has also been reported. Children who are detainees and 
incarcerated with adults may also be required to 
perform forced labor.88
Relapse rates for people released from com-
pulsory drug detention centers are very 
high. For example, very high relapse rates 
have been reported in Cambodia and 
China, with more than 90 per cent of 
people who use heroin relapsing after 
release.89  UNODC and WHO have stated 
that “the human rights of people should 
never be restricted on the grounds of treat-
ment and rehabilitation” and that “inhumane 
COMPULSORY DETENTION AND EFFECTIVE DRUG TREATMENT: ANTAGONISTS IN MALAYSIA
When comparing health outcomes of compulsory drug detention centers to voluntary centers in community settings that 
use evidenced-based methods, the differences are extraordinary. In Malaysia, where the two systems exist side-by-side, 
participants in one study included 89 people from compulsory centers and 95 from voluntary centers, all of whom who 
were found to have problematic opioid use. The participants had drug tests and interviews on entry to the centers and 
repeatedly after release (at one, three, six, nine and 12 months after release).90 People held in compulsory centers relapsed 
at a much higher rate than those from voluntary centers. One month after release, 51 per cent of those from compulsory 
centers were opioid-free, compared with 90 per cent of those from voluntary centers.91 After six months, only 19 per cent 
of those from compulsory centers were opioid-free, compared to 69 per cent from the voluntary centers. At the voluntary 
centers, people were assessed at the time of entry into the program, placed on methadone, and then allowed to use a 
variety of treatments, including psychosocial counselling and recreational activities. 
The main difference between those who were held in compulsory centers and those who attended the voluntary centers 
was that methadone was available as part of an opioid substitution therapy at the voluntary centers, whereas it was not at 
the compulsory centers. In spite of the radically different outcomes between the two different approaches in Malaysia, the 
study noted that compulsory drug detention centers in Malaysia continue to exist because of a zero-tolerance attitude in 
the country to drug use, and a lack of recognition of the effectiveness of voluntary centers compared to the ineffectiveness 
of compulsory ones. 92 
“In a 
number of 
countries, nearly half or 
more of the prison population 
comprise people who use drugs, 
for whom incarceration 
has no effect in reducing or 
altering drug use patterns. Such 
wasteful policies are a huge 
burden on the taxpayers.”
Anand Grover, member of the Global 
Commission on Drug Policy, South 
Africa, August 2017     22
or degrading practices and punishment should never be part 
of treatment of drug dependence.”93 They have also indicated 
that “neither detention nor forced labor have been recognized 
by science as treatment for drug use disorders.”94 Moreover, in 
2012, 12 UN entities issued a joint statement through the UN 
Joint Program on HIV/AIDS, calling for the closure of compulso-
ry drug detention centers.95 
Health outcomes of compulsory drug detention centers, as is 
well documented, result in high rates of relapse within a year 
of release, while health outcomes of voluntary treatment in 
community settings using evidenced approaches result in low 
relapse rates. Nevertheless, data indicates that states have been 
reluctant to change their approach and close compulsory deten-
tion centers, despite calls by the UN, medical experts, and civil 
society. Although the population of compulsory drug detention 
centers decreased by 4 per cent between 2012 and 2014 in East 
and Southeast Asian countries, subsequent data through 2018 
indicates that there have been no significant decreases in some 
countries, while there has actually been an increase in others.96 
comPulSory dEtEntion in PrivatE drug 
trEatmEnt cEntErS
Although compulsory drug detention centers operated by 
states have received much attention, an equally troubling 
issue concerns private drug treatment centers that engage 
in practices that violate international law and in many cases 
national law as well. 
The state has an international obligation to prevent human 
rights violations, to ensure respect and protection of human 
rights, and to provide a remedy when violations occur. These 
obligations are not limited to state action, but also include insti-
tutions such as private drug treatment centers. The state has an 
obligation to ensure that no one is coerced against their will 
into a private drug treatment center, and that any treatment 
is based on informed consent; evidence-based health care is 
practiced; the crime of torture is not being perpetrated; that 
other forms of cruel, inhuman, and degrading treatment or 
punishment are not practiced; people are being treated with 
humanity and respect for their dignity; and that the rights to 
DRUG COURTS AS A FORM OF COERCION
Coercive entry into private facilities may result from the 
actions of drug courts. A number of countries have im-
plemented so-called drug courts – most notably the US, 
which has over 3,000 such courts – as a way to stop incar-
cerating low-level drug offenders by diverting them into 
court-supervised treatment programs. While seemingly 
a more compassionate approach, drug courts are deeply 
flawed.
In Latin America and the Caribbean, drug courts provide 
those charged with a drug-related offense, including drug 
use or possession, with a choice between imprisonment 
or drug treatment. While drug treatment centers can be 
public in some countries, in many countries in Latin Ame-
rica and the Caribbean they are overwhelmingly private. 
For example, Mexico has around 2,000 residential treat-
ment centers, but only 43 are public. In Puerto Rico, 85 
percent of residential treatment facilities are operated by 
private entities.101 
Both WHO and UNODC have acknowledged that coer-
cion is present in the decision-making process, but have 
argued that the individual still has a choice.102 The Office 
of the High Commissioner for Human Rights has argued 
that any decision to have treatment is coercive if the alter-
native is prison, and that such coercion is a violation of the 
right to health.103 In addition, treatment may not be necessary 
because some participants may not be dependent.104  
The Global Commission reiterates its position in previous 
reports that drug courts are a conceptually flawed and in-
sufficient approach.105 Drug treatment should be a matter 
for health professionals working in the health sector and 
should never involve the criminal justice system. Coercing 
people into treatment through the threat of a criminal 
sanction is wholly unethical and counterproductive. It is 
concerning that drug courts are becoming increasingly 
common in the Caribbean and Latin America as the US, 
through the Organization of American States, promotes 
this extremely controversial approach.
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life, privacy, and to food, water, and sanitation, are protected. 
In practice, this means that states have an obligation to re-
gister and authorize the operations of private drug treatment 
centers; to set minimum standards of conduct and care at 
such facilities; to conduct regular inspections, including sur-
prise inspections; to undertake prompt, impartial, and effec-
tive investigations when there are complaints of human rights 
violations; and to sanction non-compliant facilities up to and 
including closure. 
Several studies have found that many human rights violations 
occur at such facilities in a number of countries and territories 
in Latin America and the Caribbean, including Brazil, Chile, Co-
lombia, Costa Rica, the Dominican Republic, Guatemala, Mexi-
co, Panama, and Puerto Rico.97 People are frequently brought 
to these private facilities against their will by family members, 
law enforcement officials, or staff of private centers. It has 
been reported that these centers try to intimidate people into 
signing consent forms by threating them and their families 
if they refuse to do so.98 Once in these facilities, it may be 
difficult to leave. In some facilities, attempts to leave without 
authorization are severely punished, including by beatings or 
other physical abuse.99 
The private drug treatment centers reviewed in the studies of 
Latin American and Caribbean countries and territories view 
drug use and drug dependency largely as a moral failing. 
They overwhelmingly use an abstinence-based approach to 
treatment. This approach is frequently combined with harsh 
discipline, cruel punishments, humiliation, confrontational 
therapy, and in the case of church-run facilities, an appeal for 
people who use drugs to discover a new-found belief in God 
as a way to abandon drug use. The strict disciplinary approach 
often results in beating, kicking, and other forms of physical 
abuse for minor infractions of the rules, which sometimes has 
resulted in loss of life.100
adminiStrativE dEtEntion
Administrative detention can take several forms. Perhaps the 
best-known form of administrative detention is a decision 
by the state to detain a person because his or her drug use 
is considered to constitute either a danger to themselves 
or to others. This type of administrative detention is found 
in a number of states and is most frequently provided for 
under psychiatric legislation, rather than legislation appli-
cable to drug use. In a joint document, WHO and UNODC 
stated that compulsory treatment may be legally permitted 
“only in exceptional crisis situations of high risk to self or 
others,” but added that “neither detention nor forced labor 
have been recognized as treatment for drug use disorders.”106 
However, such a standard, even with its qualifications, is pro-
blematic because it conflicts with the human rights standard 
that health care must be based on voluntary and informed 
consent, and that a person has the right to refuse treatment 
and leave a treatment setting. 
Pregnant women
Another area where administrative detention is practiced 
concerns pregnant women who are drug dependent. In 
Norway, for example, a 1996 law authorizes the authorities 
ADMINISTRATIVE DETENTION IN SWEDEN
The Swedish Care of Persons with Substance Use Disor-
ders in Certain Cases Act states that if as a consequence 
of continuing problematic drug use anyone is placing 
their physical or mental health in serious danger, is run-
ning a clear risk of destroying their life, or if there is a 
fear that they may seriously harm themselves or a per-
son close to them, a court may decide on compulsory 
care, provided that the care cannot be carried out in any 
other way. The purpose of compulsory care under this 
Swedish law is to motivate the individual to seek volun-
tary treatment for a limited period of time (a maximum 
of six months). According to the Swedish government, 
75 per cent of those who are subjected to compulsory 
care choose to transfer to voluntary treatment.107  
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to detain a woman who is drug dependent in in-patient treat-
ment without her consent if the situation of her drug use 
makes it reasonably likely that the fetus could be harmed and 
if voluntary health measures are insufficient. In this context, 
the fetus is favored over the woman’s right to liberty because 
of the potential risk of harm. Nevertheless, the Norwegian 
case appears to be an isolated one, at least in Europe. 108 
In the US state of Wisconsin, a 1997 law permits the state to 
take into custody a pregnant woman who “exhibits a habi-
tual lack of self-control over her drug use” if the state deter-
mines that she presents a “substantial risk” to the “physical 
health of the ‘unborn child.’” In 2017, the US Supreme Court 
vacated a lower court stay blocking enforcement of the law, 
and ruled that the state may continue to enforce the law until 
the appeals process was completed.109 Other states in the United 
States have restrictions that may threaten pregnant women 
who use illegal drugs with criminal sanctions, require doctors 
to report prenatal drug exposure, or consider prenatal drug 
exposure as a factor in child welfare legal determinations, 
which can lead to termination of parental rights on the 
grounds of child abuse or neglect.110 
While the use of illegal drugs can have harmful effects on 
a fetus, legal sanctions, restrictions, and reporting require-
ments concerning pregnant women who use drugs have 
generally been resisted by health advocates. They argue that 
problems associated with pregnant women who use drugs 
or who are drug dependent should be dealt with by health 
professionals, and that legal sanctions, restrictions, and re-
porting requirements will drive pregnant women who use 
drugs away from vital health services, and jeopardize their 
well-being and right to health.111 WHO has published guide-
lines for the identification and management of substance 
use during pregnancy. 112 
 
undocumented migrants
Another area where administrative detention is applicable 
concerns people who use drugs and who are detained as un-
documented migrants, as well as those subject to deporta-
tion orders. The time of confinement in immigrant/deporta-
tion facilities varies considerably from country to country. In 
some countries, it may approximate 30 days or fewer, while 
in others it may be for much longer periods. 
It was reported that drug use and drug dealing were 
widespread in an immigration removal center in the United 
Kingdom. In addition, a significant degree of violence was 
reported at the facility, and detainees were reported to inflict 
self-harm, including attempted suicide.113 A contributing 
factor is that those with serious criminal records are mixed 
with immigration offenders and applicants for asylum.114 
At Australia’s largest detention facility, used both for immigra-
tion removals and undocumented migrants seeking refugee 
status, it was reported that drugs were widely available. Be-
cause of the stressful environment in the detention facility, 
potential deportees and migrants resorted to substance use 
to deal with the difficult situation.115 
In the United States, there has been a sharp increase in de-
tention of undocumented migrants in recent years, rising 
from 6,800 in 1994 to 40,500 in 2017. A major criticism of 
government policy has been a lack of adequate health care 
for those in administrative detention.116  
At some US government-funded youth shelters, children 
were regularly given, and in some cases compelled to take, 
a range of psychotropic drugs to manage their trauma af-
ter being detained, and in several instances separated from 
their parents. It was alleged in 2018 that children were given 
substances when their condition did not require it and without 
their parents’ consent.117 After a lawsuit challenging these 
practices, a federal court ordered the US government to seek 
consent from immigrant parents before their children were 
administered psychotropic drugs.118 
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Policy rEcommEndationS from thE global commiSSion
The levels of incarceration over the last 30 years are unprece-
dented in times of peace and do not correspond to a similar 
increase in crime or criminal activity, but are instead caused by 
the increasing reliance of justice systems on incarceration as 
means of harsh punishment. This overreliance on incarcera-
tion is creating short- and long-term challenges for societies, 
ranging from disproportionate sentences to over-incarcera-
tion, especially of people from poor and marginalized com-
munities, and favoring incarceration for minor offenses rather 
than other serious crimes (such as fi nancial crimes). Incarcera-
tion also results in higher rates of morbidity and mortality for 
incarcerated people, with their vulnerability to infections (par-
ticularly tuberculosis and drug-resistant forms of tuberculosis) 
and injuries increasing once they have been arrested.
The current levels of incarceration prevent countries from ful-
fi lling their human rights and international obligations with 
regard to their incarcerated populations. Since 2011, the 
Global Commission on Drug Policy has called for reviews of 
the current criminal justice and correctional systems global-
ly, to favor alternatives to incarceration, to end disproportio-
nate sentences, and to decriminalize drug use. Following this 
pathway will move us away from the harms of punitive drug 
policies toward policies centered on justice, dignity, and hu-
man rights for all. 
rEcommEndation 1: States must end all penalties – 
both criminal and civil – for the possession and cultiva-
tion of drugs for personal consumption.  Millions of people 
around the world use drugs and do so without causing any 
harm to others. To criminalize people who use drugs is inef-
fective and harmful, and undermines the principle of human 
dignity and the rule of law. States must implement alterna-
tives to punishment, such as diversion away from the criminal 
justice system, for all low-level, non-violent actors in the drug 
trade, such as those engaging in social supply, drug couriers, 
user-dealers, and cultivators of illicit crops.  
The Justice and Correction Section of the United Nations Multidimensional Integrated 
Stabilization Mission in Mali (MINUSMA). © UN Photo/Harandane Dicko 2018.
rEcommEndation 2: States must end disproportionate 
sentencing and punishment for drug-related offenses, 
and recognize that over-incarceration impacts negatively 
on public health and social cohesion. The never-seen-be-
fore level of overreliance on incarceration observed globally in 
the last decades has negatively impacted public health, social 
cohesion, and many other global development objectives. De-
privation of liberty is the wrong response to drug use and to 
non-violent petty crime generated by the illegal market.
rEcommEndation 3: States must ensure primary health 
care is available and the right to health is applicable to all 
people on a non-discriminatory basis, including people 
detained against their will. Incarcerated people, people 
who use drugs and drug-dependent people must not be 
subjected to discrimination in the provision of health care. 
The right to health extends to assessment and treatment for 
drug dependence, and harm reduction means have been 
recognized as part of the right to health for people who use 
drugs. Health care must be based on confidentiality. People 
confined in compulsory drug detention facilities should be 
released and, for those detainees concerned, encouraged to 
seek evidence-based and tailored treatment for drug depen-
dence in voluntary centers in community settings
rEcommEndation 4: Practices that violate human rights 
of people deprived of liberty must be forbidden, their 
perpetrators brought to justice, and compensation awar-
ded to victims as provided for in human rights law.  These 
practices include, but are not limited to, torture, cruel, inhu-
mane and degrading treatment or punishment, overcrowding, 
confinement, forced labor, arbitrary and unlawful detention, 
and violations of the right to security of the person, the right 
to be treated with humanity and respect for one’s dignity, or 
the right to adequate food.
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